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ABSTRACT	1	
Specific	reactive	oxygen	species	(ROS)	from	different		sources,	might	lead	to	different	and	even	2	
opposite,	cellular	effects.	We	studied	the	production	of	specific	ROS	resulting	from	the	exposure	3	
of	human	umbilical	veins	endothelial	cells	(HUVEC)	to	H2O2	derived	from	the	natural	antioxidant	4	
epigallocathechin	gallate	(EGCG)	or	from	the	exposure	to	IL-1β	using	a	fluorogenic	probe	and	flow	5	
cytometry,	and	evaluated	by	western	blot	analysis	and	immunocytochemistry	the	associated	6	
expression	of	transcription	factors	sensitive	to	both	inflammatory	and	oxidative	stress,	such	as	NF-7	
kB	and	Nrf2,	and	some	downstream	activated	genes	such	as	cyclooxygenase-2	(COX-2)	and	8	
hemeoxygenase	1	(HO-1).	The	results	obtained	showed	that	exogenously–generated	H2O2	induce	9	
anti-inflammatory	and	antioxidant	effects	in	HUVECs	counteracting	the	pro-inflammatory	and	pro-10	
oxidant	effect	of	IL-1β	related	to	the	production	of	superoxide	anions.	The	underlying	mechanisms	11	
resulting	from	the	extracellular	production	of	H2O2,	include	1)	Nrf2	nuclear	translocation	and	the	12	
enhanced	expression	of	antioxidant	enzymes	such	as	HO-1,	and	2)	the	previously	unreported	13	
inhibition	of	NF-kB	and	COX-2	expression.	Overall,	these	findings	provide	evidence	that	the	14	
production	of	specific	reactive	oxygen	species	finely	tunes	endothelial	cell	function	and	might	be	15	
relevant	for	the	reappraisal	of	the	effects	of	exogenous	antioxidants	in	the	context	of	16	
cardiovascular	diseases).	17	
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INTRODUCTION	1	
We	previously	demonstrated	that	short	term	challenge	with	extracellular	generated	H2O2	resulting	2	
from	epigallocatechin-3-gallate	(EGCG)	increases	COX-1	but	not	COX-2	prostacyclin	(PGI2)	3	
production	by	endothelial	cells	[1].	4	
The	present	study	aimed	at	evaluating	the	effects	of	EGCG–generated	H2O2	in	human	endothelial	5	
cells	in	the presence	of	a	proinflammatory	stimulus.	In	particular,	we	looked	at	the	production	of	6	
specific	reactive	oxygen	species	(ROS)	and	at	the	expression	of	transcription	factors	sensitive	to	7	
both	inflammatory	and	oxidative	stress,	such	as	NF-kB	and	Nrf2,	and	some	downstream	activated	8	
genes	such	as	COX-2	and	HO-1.	A	simultaneous	exposure	to	pro-inflammatory	mediators	and	ROS	9	
is	likely	to	occur	in	inflammatory	states	and	for	instance,	it	is	well	accepted	that	endothelial	10	
damage	characterized	by	the	acquisition	of	a	pro-inflammatory	phenotype	worsened	by	oxidative	11	
stress	is	a	hallmark	in	the	development	and	progression	of	cardiovascular	disease	[2].	Indeed,	ROS	12	
induce	the	expression	of	several	adhesion	molecules,	which	in	turn	promote	the	adhesion	of	13	
inflammatory	cells	[3].	14	
Within	a	specific	cell	type,	ROS	may	derive	by	a	number	of	different	sources,	either	from	biological	15	
processes	that	release	ROS	as	a	byproduct	(e.g.	oxidative	phosphorylation	in	mitochondria),	or	16	
from	processes	that	generate	ROS	intentionally	(either	in	molecular	synthesis	or	breakdown,	as	17	
part	of	a	signal	transduction	pathway,	or	as	part	of	a	cell	defense	mechanism).	Among	them,	ROS	18	
and	in	particular	superoxide	anion	(O2-)	may	be	also	produced	by	NAD(P)H	oxidases,	sometimes	in	19	
response	to	inflammatory	cytokines	such	as	IL-1β	[4,5].	In	addition,	ROS	may	also	be	generated	by	20	
antioxidant	molecules	as	a	first	step	of	an	antioxidant	signal	[6].	Depending	on	the	level	of	ROS	21	
and	possibly	also	on	the	specific	ROS	produced	[7],	different	redox-sensitive	transcription	factors	22	
are	activated	and	coordinate	distinct,	cell	specific	biological	responses.	On	the	one	side,	a	low	and	23	
	 4	
quickly	reversible/transient	oxidative	stress	generated	by	antioxidant	polyphenols	such	EGCG	[8],	1	
induces	nuclear	factor	erythroid	2-related	factor	2	(Nrf2),	a	transcription	factor	implicated	in	the	2	
transactivation	of	genes	coding	for	antioxidant	enzymes	[9,10];	on	the	other	side,	an	intermediate	3	
amount	of	ROS	can	trigger	an	inflammatory	response	through	the	activation	of	NF-kB	[7].	In	4	
addition,	proinflammatory	cytokines	such	as	IL-1β	and	TNFα	have	been	reported	to	produce	ROS	5	
and	in	turn	to	activate	NF-kB	and	downstream	inflammatory	genes	such	as	COX-2,	in	several	6	
cellular	models	[11].	The	redox	dependence	of	NF-kB	activation	by	IL-1β	was	first	shown	by	Bonizzi	7	
and	colleagues,	which	demonstrated	how	ROS	production	was	required	for	NF-kB	activation	by	IL-8	
1β	in	both	lymphoid	and	monocytic	cells,	but	not	in	epithelial	cells	[12].		9	
ROS	affect	NF-kB	signaling	in	several	ways;	for	instance	ROS	often	stimulate	the	NF-κB	pathway	in	10	
the	cytoplasm,	but	inhibit	NF-κB	activity	in	the	nucleus	[4,13].	Moreover,	ROS	from	different	11	
origins	have	been	reported	to	both	activate	or	to	repress	NF-κB	signaling	and	there	are	apparently	12	
contradictory	information	on	whether	H2O2	activates	or	inhibits	NF-κB	[7,14].	Similarly,	there	are	13	
few	and	inconsistent	data	on	EGCG	and	NFkB	activation	in	endothelial	cells	[15,16].		14	
The	toxic	buildup	of	ROS	and	cellular	oxidation	is	usually	alleviated	by	enzymes	such	as	the	15	
superoxide	dismutases	(SOD)	and	catalase,	which	manage	the	excessive	production	of	O2-	and	16	
H2O2,	respectively	[17].	In	particular,	it	has	also	been	suggested	that	cells	respond	to	oxidative	17	
stress	by	activating	Nrf	2-antioxidant	response	element	(ARE)-mediated	defensive	cellular	18	
response.	The	ARE-regulated	genes	are	involved	in	the	production	of	direct	antioxidant	(e.g.	HO-1)	19	
as	well	as	in	the	direct	inactivation	of	ROS	(e.g.	catalase,	MnSOD).	There	are	a	number	of	20	
compounds	derived	from	natural	sources	that	act	as	ARE	inducers	[6]	and	EGCG	has	also	been	21	
recently	described	to	activate	Nrf2	and	downstream	ARE-containing	genes	in	specific	cells	[18,19].		22	
	 5	
Thus,	there	may	be	a	difference	in	the	contribution	of	ROS	to	various	cellular	processes,	which	in	1	
turn	could	limit	the	effectiveness	of	specific	antioxidants.	Moreover,	not	ROS	per	se,	but	rather	an	2	
unopposed	generation	of	specific	ROS	may	be	detrimental	for	the	endothelial	integrity,	while	3	
others	ROS	(e.g.	H2O2)	could	determine	beneficial	effects,	especially	under	specific	circumstances	4	
such	as	inflammation.	Therefore,	a	better	understanding	of	how	the	type	and	the	temporal	5	
aspects	of	ROS	production	could	both	affect	the	inflammatory	response	and	tune	the	synthesis	of	6	
antioxidant	enzymes	and/or	oxidative	stress	in	endothelial	cells	under	inflammatory	conditions,	is	7	
of	potential	relevance	to	clarify	the	final	effects	of	oxidative	stress	in	the	setting	of	cardiovascular	8	
disease.	9	
MATERIALS	AND	METHODS	10	
Cell	culture	11	
Human	umbilical	vein	endothelial	cells	(HUVECs)	obtained	as	previously	published	[20],	were	12	
grown	in	medium	199	(M199,	Invitrogen,	S.	Giuliano	Milanese,	Milan,	Italy)	supplemented	with	13	
15%	FCS	(Euroclone;	Pero,	Milan,	Italy),	gentamicin	(40	g/ml,	Invitrogen),	endothelial	cell	growth	14	
factor	(25	μg/ml),	and	heparin	(100	µg/ml),	at	37°C	in	a	humidified	5%	CO2	atmosphere.	Cells	were	15	
identified	as	endothelial	by	their	morphology	and	the	presence	of	CD31-related	antigen.	All	16	
experiments	were	performed	on	cells	at	the	second	passage.	HUVECs	were	seeded	at	equal	17	
density	either	in	24-well	plates	(7×104/well)	or	in	6-well	plates	(3×105/well)	and	incubated	in	M199	18	
supplemented	with	5%	FCS.	Selected	experiments	were	carried	out	in	the	presence	of	EGCG	(1–19	
100	µM,	Sigma),	2-tert-butyl-4-quinone	(BQT,	Sigma),	catalase	(CAT;	300	U/mL,	Sigma),	20	
diphenyleneiodonium	chloride	(DPI,	1-10	µM,	Sigma),	IL-1β	(0.2-2ng/mL,	Roche).	Inhibitors	were	21	
added	30	min	before	the	stimulus.	22	
	 6	
Measurement	of	reactive	oxygen	species	(ROS)	1	
ROS	levels	were	determined	by	flow-cytometry	(Beckman	Coulter	Epics	XL	Flow	Cytometer)	using	2	
2′,7′-dichlorfluorescein-diacetate	(DCFH-DA,	Sigma-Aldrich),	a	cell	membrane-permeable	3	
fluorogenic	probe.	The	acetate	groups	of	this	probe	are	enzymatically	cleaved	inside	living	cells.	4	
The	probe	can	then	be	oxidized	by	intracellular	oxidants	(ROS)	to	give	a	product,	DCF,	which	emits	5	
a	strong,	green	fluorescence	(λex = 490nm;	λem = 529	nm).	The	fluorescence	intensity	increases	in	6	
proportion	to	the	level	of	cellular	oxidants	and	is	expressed	as	percent	increase	versus	basal	7	
values.	ROS	were	evaluated	in	cells	treated	with	either	EGCG	(10–100	µM)	or	Il-1β	(2	ng/mL)	for	8	
different	periods	(15	min-24	hours).	For	short	term	experiments	(less	than	1	hour),	cells	were	9	
incubated	for	30	minutes	with	DCFH-DA	before	the	further	challenge	with	the	specific	stimulus.	10	
For	long	term	experiments	(more	than	1	hour)	DCFH-DA	loading	was	performed	30	minutes	before	11	
the	end	of	the	incubation	time.	To	detect	the	potential	ability	of	H2O2/EGCG	to	inhibit	the	12	
production	of	ROS	in	the	presence	of	Il-1β,	the	cells	were	pretreated	with	EGCG	for	30	min.	13	
Subsequently,	Il-1β	(2	ng/mL)	was	added,	and	the	cells	were	incubated	for	a	further	6-24	h.	14	
Selected	experiments	were	performed	with	catalase	(CAT;	300	U/ml,	Sigma)	or	15	
diphenyleneiodonium	chloride	(DPI,	1-10	µM,	Sigma)	added	30	min	before	the	stimulus.	16	
Western	blot	analysis	17	
At	the	end	of	incubations,	cells	were	harvested	in	lysis	buffer	[50	mM	Tris-HCl,	pH	7.4;	150	mM	18	
NaCl;	1%	(v/v)	Nonidet	P-40;	25	mM	NaF;	0.5%	(w/v)	sodium	deoxycholate;	10%	(w/v)	SDS;	1	mM	19	
EGTA;	1	mM	phenylmethylsulfonyl	fluoride;	1	mM	orthovanadate;	and	10	mM	sodium	20	
pyrophosphate,	supplemented	with	Complete	protease	inhibitor	mixture	obtained	from	Roche,	21	
Mannheim,	Germany].	After	quantization	by	Lowry’s	method,	equal	amounts	of	cell	protein	(20-40	22	
µg)	were	loaded	onto	10%	SDS-acrylamide	gels.	At	the	end	of	the	run,	proteins	were	transferred	to	23	
	 7	
polyvinylidene	difluoride	(PVDF)	membranes	and	incubated	with	polyclonal	antibodies	against	1	
MnSOD	(1:1000,	Cell	Signaling),	HO-1	(1:1000,	Cell	Signaling),	IKBα	(1:1000,	Cell	Signaling)	pIKBa	2	
(1:1000,	Cell	Signaling)	and	COX-2	(1:400,	Cayman	Chemical)	overnight	and	then	with	suitable	3	
peroxidase-conjugated	secondary	antibodies	for	1	h.	Proteins	were	detected	by	4	
chemiluminescence	(Amersham	Biosciences,	Piscataway,	NJ,	USA).	Loading	control	was	performed	5	
using	actin	immunodetection.	In	selected	experiments	cytoplasmic	and	nuclear	proteins	were	6	
extracted	from	HUVECs	using	a	Nuclear	protein	extraction	KIT	according	to	the	manufacturer's	7	
instructions	(ProteoJet,	Fermentas)	and	Nrf2	was	measured	by	Western	blot	analysis	(1:500,	8	
Abcam).	9	
NF-kB	nuclear	translocation	10	
HUVECs	were	seeded	in	24-well	plates	on	a	sterile	cover	slip	previously	placed	on	the	well	bottom.	11	
Cells	were	treated	with	Il-1β	2ng/mL	for	45	min,	the	culture	medium	was	removed	and	cells	were	12	
washed	twice	with	sterile	PBS	to	remove	any	residue	of	the	medium.	Cells	were	then	fixed	with	4%	13	
paraformaldehyde	for	10	min	at	room	temperature,	and	washed	three	times	with	sterile	PBS	to	14	
remove	the	excess	of	paraformaldehyde.	In	order	to	saturate	aspecific	binding	sites,	cells	were	15	
blocked	for	45	min	with	a	permeabilization	solution	of	PBS	supplemented	with	1%	FBS	and	0.1%	16	
Triton	and	further	treated	for	30	min	with	a	solution	of	H2O2	(0.3%).	Subsequently,	the	solution	17	
was	removed	and	without	washing,	the	p65	primary	antibody	was	added	in	each	well	(1:50	in	PBS	18	
containing	2%	FBS,	Cell	Signaling)	and	cells	were	incubated	for	1	h	at	room	temperature.	At	the	19	
end	of	the	incubation,	cells	were	washed	three	times	with	a	PBS	solution	and	incubated	with	a	20	
biotinylated	secondary	antibody	(1:1000,	Vector)	for	30	min.	After	shortly	washing	with	PBS	21	
solution,	cells	were	incubated	for	further	30	min	with	streptavidine	peroxidase	(1:1000,	Vector).	22	
After	washing	with	PBS	solution,	positive	cells	were	detected	with	3,3'-diaminobenzidine	23	
detection	system	using	Vector	VIP,	according	to	manufacturer’s	instructions	(Vector	VIP,	Vector).	24	
	 8	
The	cover	slips	were	removed	and	turned	over	Mowiol	and	at	last	stored	at	4°C	away	from	light	1	
until	image	acquisition	using	a	Nikon	microscope	(Nikon	Eclipse,	200x	magnification).		2	
PGE2	and	PGI2	assay	3	
After	incubation,	the	culture	medium	of	EGCG-treated	cells	were	collected	and	centrifuged	at	4	
10,000	g	for	5	min.	Prostaglandin	E2	(PGE2)	or	6-keto	PGF1α,	the	stable	hydrolysis	product	of	PGI2,	5	
was	measured	with	specific	EIA	kits	(Cayman	Chemical)	according	to	the	manufacturer's	6	
instructions.	7	
MTT	cell	viability	assay	8	
HUVECs	were	seeded	in	96-well	plates	(1.5x104/well)	and	incubated	for	24	hours	in	the	absence	or	9	
presence	of	different	concentrations	of	EGCG.	10	µL	of	MTT	solution	(3-(4,5-dimethylthiazol-2-yl)-10	
2,5-diphenyltetrazolium	bromide	5	mg/mL	in	Dulbecco’s	Phosphate	Buffered	Saline,	pH=7.4)	was	11	
added	to	each	well	4	hours	before	the	end	of	treatment	at	a	final	concentration	of	5mg/ml.	12	
Afterwards	the	incubation	medium	was	removed	and	the	formazan	crystals	were	dissolved	in	100	13	
µL	of	DMSO.	Absorbance	at	570nm-630	nm	was	measured	in	a	multilabel	plate	counter	(VICTOR2–14	
Wallac).	Results	were	expressed	as	percent	of	the	absorbance	observed	in	the	absence	of	EGCG.	15	
Statistical	Analysis		16	
All	of	the	experiments	were	performed	in	at	least	three	independent	replications;	the	results	are	17	
presented	as	mean	values,	with	error	bars	representing	the	standard	error	(SE)	of	the	average	18	
value.	A	one-way	ANOVA	test	was	used	for	statistical	analysis,	followed	by	Bonferroni	post	hoc	19	
tests	for	multiple	comparisons.	A	value	of	p	<	0.05	was	considered	to	be	statistically	significant.	20	
GraphPad	Prism	5.02	(GraphPad	Software	Inc.,	La	Jolla,	CA,	USA)	was	used	to	perform	the	21	
analyses.	22	
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	1	
RESULTS	2	
EGCG-	and	Il-1β	differently	affect	ROS	production	by	HUVECs	over	time	3	
In	order	to	evaluate	the	time-dependent	effects	of	IL-1β	and	EGCG	on	ROS	production,	HUVECs	4	
were	treated	with	100	µM	EGCG	(the	concentration	previously	reported	by	Toniolo	et	al	[1],	to	5	
generate	amount	of	H2O2capable	of	affecting	cell	functions)	or	2ng/mL	IL-1β	for	different	time	6	
intervals	in	the	presence	of	the	cell	membrane-permeable	fluorogenic	probe	DCFHDA.		7	
We	first	observed	that	in	the	short	term	(5-30	min),	both	EGCG	and	IL-1β,	alone	or	in	combination	8	
increased	ROS	generation	by	HUVECs	(Fig.1).	Conversely,	challenging	the	cells	for	6	hours,	EGCG	9	
no	longer	affected	ROS	production,	while	IL-1β	effect	on	ROS	was	greater	with	respect	to	that	10	
observed	at	30	min	(324.9%±44.2	and	146.5%±8.6	vs	basal,	respectively).	Moreover,	when	HUVECs	11	
were	treated	with	IL-1β	in	the	presence	of	EGCG	for	6	or	24	hours,	a	concentration-dependent	12	
decrease	in	ROS	production	was	observed	(Fig.	2A	and	2B).	Altogether,	these	results	suggest	that	13	
the	ROS/H2O2	initially	generated	by	EGCG	might	be	responsible	for	a	delayed	antioxidant	effect.	14	
Viability,	as	assessed	by	the	MTT	test,	was	not	reduced	by	the	exposure	to	EGCG	1-100	µM	for	up	15	
to	24	hours	(data	not	shown).	16	
Effects	of	EGCG	and	IL-1β	on	redox-sensitive	transcription	factor	activation	and	downstream	17	
gene	expression		18	
In	order	to	evaluate	whether	EGCG-derived	H2O2	activates	redox-sensitive	transcription	factors,	19	
which	in	turn	could	be	responsible	for	antioxidant	and/or	antiinflammatory	activity,	we	first	20	
looked	at	the	nuclear	translocation	of	Nrf2	in	HUVECs	treated	with	either	100	µM	EGCG	or	2-tert-21	
butyl-4-quinone	(TBQ),	a	well	recognized	antioxidant	used	as	positive	control. As	reported	in	Fig.	3,	22	
	 10	
challenging	the	cells	for	1	hour	with	EGCG	increased	the	nuclear	fraction	of	Nrf2,	clearly	1	
suggesting	that	EGCG	induced	the	nuclear	translocation	of	Nrf2.	By	contrast,	IL-1β	was	not	able	to	2	
affect	Nrf2	nuclear	translocation	(data	not	shown).	Accordingly,	after	6	hours	EGCG	but	not	IL-1β	3	
increased	the	expression	of	HO-1,	an	antioxidant	enzyme	containing	ARE	in	its	promoter,	which	4	
binds	Nrf2.	This	effect,	at	least	at	this	time	point,	was	specific	for	heme	oxygenase-1	(HO-1)	since	5	
neither	the	expression	of	glutathione	peroxidase	(GPx)	nor	that	of	superoxide	dismutase	(MnSOD)	6	
was	modified	by	EGCG	(Fig.	4A,	4B	and	4C).	By	contrast,	IL-1β	increased	MnSOD	without	affecting	7	
neither	HO-1	nor	GPX	expression.		8	
We	then	analyzed	the	effects	of	EGCG	and	IL-1β	on	the	activation	of	NF-kB,	another	widely	9	
recognized	redox-sensitive	transcription	factor.	In	HUVECs	treated	with	IL-1β	the	pIkB/IkB	protein	10	
ratio	increased	in	a	time-dependent	manner,	peaking	at	30	minutes	(Fig.	5A).	The	pre-treatment	of	11	
cells	with	EGCG-generated-H2O2	prevented	NF-kB	activation,	as	observed	by	a	decreased	pIKB/IKB	12	
ratio	(Fig.	5B).	Accordingly,	a	significant	decrease	in	p65	nuclear	translocation	was	observed	in	13	
HUVECs	challenged	for	45	minutes	with	IL-1β	in	the	presence	of	EGCG	with	respect	to	untreated	14	
cells	(Fig.	5C).	Moreover,	after	6	hours,	EGCG	(10-100	µM)	decreased	the	expression	of	IL-1β-15	
induced	endothelial	COX-2	expression	(Fig.	6A)	as	well	as	the	production	of	both	the	prostacyclin	16	
metabolite	6-keto-PGF1α	and	PGE2	(Fig.	6B	and	6C),	further	suggesting	a	role	for	H2O2	in	tuning	the	17	
IL-1β	effects	on	endothelial	cells.		18	
Overall,	this	data	demonstrates	that	EGCG	and	IL-1β	exert	opposite	effects	on	the	activation	of	19	
both	Nrf2	and	NF-kB	as	well	as	on	the	expression	of	some	downstream	target	genes	possibly	due	20	
to	the	generation	of	different	ROS.		21	
	 11	
IL1β-produced	ROS	are	inhibited	by	DPI	but	not	by	catalase	1	
In	order	to	further	explore	the	oxygen	species	involved	in	IL-1β-mediated	pro-oxidant	and	pro-2	
inflammatory	effects,	HUVECs	were	treated	with	IL-1β	in	the	presence	of	different	antioxidant	3	
molecules.	At	variance	with	what	observed	with	EGCG	(see	also	[1]),	catalase	did	not	affect	the	4	
generation	of	ROS	induced	by	the	treatment	of	HUVECs	with	IL-1β	(0.2-2ng/mL)	for	either	6	or	24	5	
hours	(Fig.	7A	and	7B).	Conversely,	challenging	cells	with	IL-1β	(0.2-2ng/mL)	in	the	presence	of	the	6	
NADPH	inhibitor	diphenyleneiodonium	chloride	(DPI,	1-10	µM)	for	6	hours,	the	generation	of	ROS	7	
was	reduced	in	a	concentration-dependent	manner	(Fig.	7C).	Overall,	these	data	indicate	that	the	8	
reactive	oxygen	species	produced	by	IL-1β	in	HUVECs	are	dependent	on	the	activation	of	NADPH	9	
oxidase	and	thus	are	mainly	represented	by	superoxide	anion.	10	
The	NADPH	inhibitor	DPI	and	H2O2	from	EGCG	inhibit	IL1β-stimulated	activation	of	NF-kB	in	11	
HUVECs	12	
In	order	to	understand	the	contribution	of	specific	oxygen	species	in	NF-kB	activation,	we	further	13	
analyzed	the	effects	of	DPI	and	catalase	on	IL1β-induced	NF-kB	activation.	Similarly	to	what	14	
observed	for	EGCG,	treatment	of	cells	with	DPI	prevented	IL-1β-induced	NF-kB	activation	15	
evaluated	as	a	decreased	pIkB/IkB	ratio	(Fig.	8A),	suggesting	that	NFkB	activation	requires	IL-1β-16	
induced	ROS	production.	Conversely,	catalase	was	unable	to	prevent	IL-1β-mediated	NF-kB	17	
activation	(Fig.	8B).	More	interestingly	and	quite	unexpectedly,	catalase	counteracted	EGCG	18	
inhibition	of	IL-1β-mediated	NF-kB	activation,	clearly	suggesting	that	specific	oxygen	species	are	19	
crucial	for	either	activation	(superoxide	anion)	or	inhibition	(H2O2)	of	NF-kB	(Fig.	8B).	20	
	21	
	 12	
DISCUSSION	1	
We	demonstrated	that	short-term	exposure	to	H2O2,	generated	from	high	concentrations	of	EGCG,	2	
leads	to	antioxidant	and	anti-inflammatory	effects	in	HUVECs	through	the	activation	of	Nrf2	and	3	
the	inhibition	of	NF-kB	and	the	downstream-activated	genes	HO-1	and	COX-2,	respectively.	4	
Consistent	with	the	production	of	different	reactive	oxygen	species,	IL-1β	induces	a	time-5	
dependent	activation	of	NF-kB	in	HUVECs,	which	is	blocked	by	DPI.	Notably,	we	provide	the	6	
previously	unreported	evidence	that	IL1β-induced	COX-2	and	NF-kB	activation	is	also	inhibited	by	7	
H2O2	produced	by	EGCG,	and	this	effect	is	prevented	by	catalase.		8	
A	simultaneous	exposure	to	pro-inflammatory	mediators	and	ROS	is	likely	to	occur	in	9	
inflammatory	states	and	contributes	for	instance	to	endothelial	cell	dysfunction,	which	is	often	10	
associated	with	cardiovascular	disease	[7,21,22].	The	cellular	response	to	these	environmental	11	
changes	depends	on	a	number	of	factors	such	as	the	amount	and	the	type	of	ROS	produced	by	a	12	
number	of	sources,	such	as	pro-inflammatory	cytokines,	as	well	as	by	the	availability	of	13	
antioxidant	defenses,	such	as	cell-specific	antioxidant	enzymes	[7,17].	In	this	complex	scenario,	14	
the	use	of	exogenous	antioxidants	may	affect	the	cellular	response	sometimes	leading	to	15	
undesired	effects	[17,23].	The	present	paper	was	aimed	at	evaluating	the	effects	of	specific	ROS	16	
species	likely	to	be	present	during	inflammatory	conditions	in	the	endothelial	cells	environment	by	17	
looking	at	the	expression	of	transcription	factors	such	as	NF-kB	and	Nrf2,	sensitive	to	both	18	
inflammatory	and	oxidative	stress,	and	some	downstream	activated	genes.	19	
EGCG	is	the	major	bioactive	polyphenol	in	green	tea.	EGCG	has	been	reported	also	by	our	group	to	20	
undergo	auto-oxidation	and	to	generate	H2O2,	which	in	turn	is	known	to	be	responsible	for	the	21	
long-term	antioxidant	activity	[1,19].	With	respect	to	ROS	production,	different	laboratories	22	
reported	a	wide	range	of	variable	results	in	terms	of	extent	and	rate	of	ROS	production,	which	23	
could	be	explained	by	the	use	of	different	cell	culture	media	and/or	time	of	exposure	[24][25].	In	24	
	 13	
the	context	of	our	experimental	set-up,	we	would	like	to	stress	the	fact	that	EGCG	was	used	at	1	
high	concentration	that	did	not	affect	endothelial	cell	viability	as	a	natural	source	of	H2O2	and	we	2	
are	not	implying	any	potential	effect	described	in	the	manuscript	as	a	mechanism	of	the	anti-3	
inflammatory	action	of	EGCG. Indeed,	even	if	accumulation	and	different	sources	of	catechins	may	4	
result	in	increased	plasma	concentrations,	the	single	consumption	of	the	extract	of	10	g	of	green	5	
tea	(similar	to	16	ounces	of	green	tea	infusion)	yielded	plasma	concentrations	of	tea	catechins	of	6	
about	1-3	µM,	with	a	half-life	of	5	hours	[26].	Nevertheless, ROS	generation	by	EGCG,	at	7	
concentrations	similar	to	those	used	in	our	study,	have	also	been	reported	to	contribute	to	8	
cytoprotective	effects	[27]	as	well	as	endothelium-dependent	relaxation	[28].	9	
The	role	of	ROS	in	NF-kB	activation	has	also	been	the	subject	of	intense	studies	leading	to	10	
conflicting	results.	The	production	of	ROS	upon	IL-1β,	TNF-α	and	LPS	stimulation	has	emerged	as	11	
evidence,	but	their	role	in	NF-kB	activation	is	still	controversial	[4,7].	Korn	et	al.	reported	that,	12	
H2O2	is	capable	of	inhibiting	TNF-induced	NF-kB	activation	in	lung	epithelial	cells	by	reducing	IKKb	13	
activity	through	oxidation	of	cysteine	residues	in	the	IKK	complex	[29].	By	contrast,	it	has	been	14	
shown	that	ROS	production	was	required	for	NF-kB	activation	by	IL-1β	in	both	lymphoid	and	15	
monocytic	cells,	but	not	in	epithelial	cells	[12].	Moreover,	Ludwig	et	al.	previously	reported	that	16	
100	µM	EGCG	does	not	affect	the	nuclear	translocation	of	p65	in	TNFα-stimulated	HUVEC	[15],	17	
whereas	more	recently	Li	et	al.	demonstrated	an	inhibitory	effect	of	EGCG	on	NF-kB	activation	in	18	
cerebral	endothelial	cells	but	the	mechanism	has	not	been	studied	[16].	We	here	demonstrated	19	
for	the	first	time	that	a	short	exposure	to	EGCG-produced	H2O2	inhibits	IL-1β-induced	Nf-kB	20	
activation	in	HUVECs.	Indeed,	EGCG	decreased	pIkB/IkB	ratio,	an	index	of	NF-kB	activation	[11],	as	21	
well	as	p65	nuclear	translocation.	Notably,	catalase	prevented	the	effect	of	EGCG,	clearly	22	
suggesting	that	extracellular	H2O2	produced	by	EGCG	has	an	inhibitory	effect	on	IL-1β-mediated	23	
NF-kB	activation.	Literature	is	abundant	with	apparently	contradictory	information	on	whether	24	
	 14	
H2O2	activates	or	inhibits	NF-kB	and	it	is	still	a	matter	of	debate	which	ROS	mediates	NF-kB	1	
activation	[7,14].	Interestingly,	under	our	experimental	conditions,	NF-kB	activation	by	IL-1β	was	2	
also	inhibited	by	the	NADPH	oxidase	inhibitor	DPI,	demonstrating	that	NADPH	oxidase-derived	3	
ROS,	in	particular	superoxide	anion,	are	required	for	NF-kB	activation	by	IL-1β	in	HUVECs	and	4	
further	strengthening	the	specific	and	opposite	role	of	different	oxygen	species	in	NF-kB	5	
activation.	Accordingly,	DPI	inhibited	IL-1β-generated	ROS.	In	addition,	we	demonstrated	an	6	
increased	MnSOD	expression	in	IL-1β-treated	HUVEC.	It	has	been	already	described	that	the	7	
exposure	of	cells	to	cytokines	such	as	IL-1β	and	TNFα	leads	to	the	accumulation	of	toxic	reactive	8	
oxygen	intermediates	and,	not	surprisingly,	to	the	induction	of	a	gene,	MnSOD,	whose	product	9	
eliminates	these	radicals	from	the	cell. In	particular,	TNFα	and	IL-1β-mediated	induction	of	MnSOD	10	
has	been	shown	to	confer	protection	against	myocardial	reperfusion	injury	and	tissue	damage	due	11	
to	oxidative	stress	[30].	The	mechanisms	for	the	induction	of	MnSOD	expression	under	all	of	these	12	
conditions	is	not	completely	understood.	However,	activation	of	the	transcription	factor	NF-kB	has	13	
been	implicated	to	play	a	role	[31,32].		14	
Overall,	as	far	as	NF-kB	modulation	by	specific	ROS	in	HUVECs,	weprovide	previously	unreported	15	
data	showing	that	1)	the	activation	of	NF-kB	by	IL-1β	depends	on	the	generation	of	ROS	different	16	
from	H2O2;	2)	IL-1β,	possibly	through	NF-kB	activation,	increases	the	expression	of	the	antioxidant	17	
MnSOD;	3)	EGCG-produced	H2O2	prevents	IL-1β-mediated	Nf-kB	activation.	18	
To	further	study	the	effects	of	exogenously-generated	H2O2	/	H2O2	produced	from	a	natural	source	19	
and	IL1-β	on	endothelial	cell	activation,	we	looked	at	the	expression	of	COX-2,	a	gene	sensitive	to	20	
both	oxidative	stress	[33–35]	and	inflammatory	stimuli	[36],	which	indeed	is	also	a	well	known	NF-21	
kB	target	gene	in	endothelial	cells	[37].	We	demonstrated	that,	similarly	to	what	observed	for	NF-22	
kB,	IL-1β-enhanced	COX-2	expression	is	inhibited	by	EGCG.	Previously	it	has	been	reported	that	23	
ROS	generated	by	TNFα	or	exogenously	added	H2O2	to	cells	for	16	hours	activate	COX-2	and	the	24	
	 15	
production	of	6keto-PGF1α	and	PGE2,	which	in	turn	were	inhibited	by	the	SOD	analogue	[38].	1	
Interestingly,	however,	it	has	been	reported	that	endothelial	cells	in	the	presence	of	IL-1β	produce	2	
PGI2	only	for	short	periods	and	thereafter	PGI	synthase	is	inactivated	[39].	We	here	demonstrated	3	
that	EGCG	decreases	the	production	of	COX-2	metabolites	6keto-PGF1α	and	PGE2	when	in	the	4	
presence	of	IL-1β.	It	has	also	been	shown	that	EGCG	inhibited	COX-2	expression	in	linoleic	acid-5	
stimulated	HUVECs	through	a	mechanism	involving	ERK1/2	phosphorylation	[40].	Indeed,	we	6	
cannot	exclude	that	mechanisms	other	than	NF-kB	are	responsible	for	IL-1β-enhanced	COX-2	7	
expression	[41].	This	is	an	ubiquitous	enzyme	up-regulated	in	response	to	oxidant	stress	and	8	
inflammatory	stimuli,	and	may	play	an	important	role	in	preserving	vascular	and	metabolic	9	
homeostasis.	Indeed,	we	also	demonstrated	that	EGCG	causes	both	Nrf2	nuclear	translocation	and	10	
HO-1	induction.	Consistent	with	our	data,	there	is	evidence	that	EGCG	can	induce	HO-1	via	11	
activation	of	Nrf2	in	other	endothelial	cell	models	[18,19].		12	
Conclusions	13	
In	conclusion,	extracellular	H2O2	generated	using	high	concentrations	of	EGCG	exerts	anti-14	
inflammatory	and	antioxidant	effects	in	HUVECs	counteracting	the	pro-inflammatory	and	pro-15	
oxidant	effect	of	Il-1β.	The	mechanisms	underlining	the	effects	of	extracellular	H2O2	include	1)	Nrf2	16	
nuclear	translocation	and	the	enhanced	expression	of	antioxidant	enzymes	such	as	HO-1,	and	the	17	
previously	unreported	2)	inhibition	of	NF-kB	and	COX-2	expression.	Overall,	these	findings	provide	18	
evidence	that	the	production	of	specific	reactive	oxygen	species	finely	tunes	endothelial	cell	19	
function	and	might	be	relevant	for	the	reappraisal	of	the	effects	of	exogenous	antioxidants	in	the	20	
context	of	cardiovascular	diseases.	21	
	22	
	 16	
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FIGURE	LEGENDS	1	
Figure	1.	Effect	of	EGCG	and	IL-1β	on	ROS	production	in	HUVECs.	HUVEC	were	incubated	(30	min)	2	
with	the	cell	membrane-permeable,	ROS-sensitive	fluorogenic	probe	DHCF-DA,	and	upon	3	
treatment	with	either	EGCG	or	IL-1β	(5-30	min),	fluorescence	was	determined	by	flow	cytometry.	4	
Fluorescence	intensity	is	expressed	as	%	of	control	incubations.	5	
**P<0.01	vs	control	6	
	7	
Figure	2.	Effect	of	EGCG	on	ROS	production	induced	by	IL-1β	in	HUVECs.	HUVEC	were	treated	8	
with	EGCG	for	30	min,	followed	by	Il-1β	(2	ng/mL;	panel	A:	6	h,	panel	B:	24	h).	Cells	were	finally	9	
incubated	with	the	cell	membrane-permeable,	ROS-sensitive	fluorogenic	probe	DHCF-DA	(30	min),	10	
and	fluorescence	determined	by	flow	cytometry.	Fluorescence	intensity	is	expressed	as	%	of	11	
Control	incubations.	12	
*P<0.05,	**P<0.01,	***P<0.001	vs	Il-1β		13	
	14	
Figure	3.	Effect	of	EGCG	on	Nrf2	nuclear	translocation	in	HUVECs.	HUVEC	were	treated	with	100	15	
µM	EGCG	or	2-tert-butyl-4-quinone	(BQT)	for	1	h,	and	nuclear	proteins	were	extracted	using	a	16	
commercially	available	nuclear	protein	extraction	KIT.	Nrf2	protein	was	then	detected	by	western	17	
blotting	in	the	nuclear	and	cytoplasmic	fractions	while	GAPDH	was	monitored	as	loading	control.	18	
Panel	A:	representative	western	blot.	Panel	B:	semiquantitative	analysis	of	nuclear	Nrf2;	western	19	
blot	optical	density	was	evaluated	using	ImageJ	1.47v	(NIH,	USA)	and	Nrf2	data	were	normalized	20	
using	the	optical	density	of	corresponding	GAPDH. 21	
*P<0.05	vs	control		22	
	23	
Figure	4.	IL-1β	and	the	expression	of	Heme	oxygenase-1	(HO1),	Mn	superoxide	dismutase	24	
(MnSOD)	and	glutathione	peroxidase	(GPx)	in	HUVECs:	effect	of	EGCG.	HUVEC	were	treated	with	25	
IL-1β	and/or	EGCG	for	6	h,	and	proteins	were	detected	by	western	blotting.	β-actin	was	monitored	26	
	 21	
as	loading	control.	Panel	A:	representative	western	blot	(left	side)	and	semiquantitative	analysis	1	
(right	side)	of	the	expression	of	HO1	in	the	presence	or	absence	of	IL-1β	and/or	EGCG.	Panel	B:	2	
representative	western	blot	(left	side)	and	semiquantitative	analysis	(right	side)	of	the	expression	3	
of	MnSOD	in	the	presence	or	absence	of	IL-1β	and/or	EGCG.	Panel	C:	representative	western	blot	4	
(left	side)	and	semiquantitative	analysis	(right	side)	corresponding	β-actin.of	the	expression	of	5	
HO1	in	the	presence	or	absence	of	IL-1β	and/or	EGCG.	Western	blot	optical	density	was	evaluated	6	
using	NIH	ImageJ	software	and	data	were	normalized	using	the	optical	density	of		7	
*P<0.05,	**P<0.01	vs	control	;	###	P<0.001	vs	IL-1β		8	
	9	
Figure	5.	IL-1β	and	the	activation	of	Nf-kB	in	HUVECs:	effect	of	EGCG.	HUVEC	were	treated	with	10	
IL-1β	in	the	absence	(5-30	min)	or	presence	(30	min)	of	EGCG.	IkBα	and	its		phosphorylated	form	11	
(p-IkBα)	were	analysed	by	western	blotting	and	β-actin	was	monitored	as	loading	control,	while	12	
nuclear	translocation	of	p65	was	monitored	by	immunocytochemistry.	Panel	A,	upper	part:	13	
representative	western	blots	of	the	effects	of	IL-1β	on	IkBα	and	its		phosphorylated	form;	Panel	A,	14	
lower	part:	semiquantitative	analysis	of	the	changes	in	the	ratio	between	p-IkBα	and	IkBα,	both	15	
normalized	for	their	corresponding	β-actin.	Panel	B,	upper	part:	representative	western	blots	of	16	
the	effects	of	EGCG	on	the	changes	induced	by	IL-1β	on	IkBα	and	its		phosphorylated	form;	Panel	17	
B,	lower	part:	semiquantitative	analysis	of	the	changes	in	the	ratio	between	p-IkBα	and	IkBα,	both	18	
normalized	for	their	corresponding	β-actin.	Western	blot	optical	density	was	evaluated	using	NIH	19	
ImageJ	software	and	data	were	normalized	using	the	optical	density	of	corresponding	β-20	
actin.Panel	C:	immunocytochemistry	of	changes	in	subcellular	p65	distribution	upon	treatment	21	
with	EGCG	and	/or	IL-1β.	Images	were	acquired	with	a	Nikon	Eclipse	TI-S	microscope,	40x	22	
magnification).		23	
**P<0.01	vs	control,	$	P<0.05	vs	IL-1β		24	
	25	
Figure	6.	IL-1β	and	the	expression	of	COX-2	in	HUVECs:	effect	of	EGCG.	HUVEC	were	treated	with	26	
IL-1β	for	6	h,	in	the	absence	or	presence	of	EGCG.	COX-2	expression	was	monitored	by	western	27	
blotting	and	β-actin	was	used	as	loading	control.	Panel	A:	representative	western	blots	of	the	28	
effects	of	EGCG	on	the	induction	of	COX-2	by	IL-1β.	Panel	B:	semiquantitative	analysis	of	the	29	
	 22	
effects	of	EGCG	on	the	induction	of	COX-2	by	IL-1β.	Panel	C:	effect	of	EGCG	on	the	production	of	1	
6ketoPGF1α	(left	side)	and	PGE2	(right	side)	induced	by	treatment	with	IL-1β.	Western	blot	optical	2	
density	was	evaluated	using	NIH	ImageJ	software	and	data	were	normalized	using	the	optical	3	
density	of	corresponding	β-actin.	Quantitation	of	eicosanoids	was	carried	out	by	commercially	4	
available	EIA.	5	
*P<0.05	vs	control;	$P<0.05	vs	IL-1β;	**P<0.01	vs	control	(Panel	A)	or	IL-1β	(Panel	B)	6	
	7	
Figure	7.	Effect	of	catalase	or	DPI	on	ROS	production	induced	by	IL-1β	in	HUVECs.	HUVEC	were	8	
treated	with	Il-1β	(2	ng/mL;	panel	A	and	C:	6	h,	panel	B:	24	h)	in	the	presence	or	absence	of	9	
catalase	(Panel	A	and	B)	or	different	concentrations	of	DPI	(Panel	C).	Cells	were	finally	incubated	10	
with	the	cell	membrane-permeable,	H2O2-sensitive	fluorogenic	probe	DHCF-DA	(30	min),	and	11	
fluorescence	determined	by	flow	cytometry.	Fluorescence	intensity	is	expressed	as	%	of	Control	12	
incubations.	13	
*P<0.05	vs	control;	**P<0.01	vs	control;	***P<0.001	vs	control;	##P<0.01	vs	IL-1β	14	
	15	
Figure	8.	IL-1β	and	the	activation	of	Nf-kB	in	HUVECs:	effect	of	EGCG	and/or	DPI	and	catalase.	16	
HUVEC	were	treated	with	IL-1β	for	30	min,	in	the	presence	or	absence	of	test	compounds.	IkBα	17	
and	its		phosphorylated	form	(p-IkBα)	were	analysed	by	western.	Panel	A:	semiquantitative	18	
analysis	of	the	changes	in	the	ratio	between	p-IkBα	and	IkBα	induced	by	IL-1β	in	the	absence	or	19	
presence	of	EGCG	and/or	DPI.	Panel	B:	semiquantitative	analysis	of	the	changes	in	the	ratio	20	
between	p-IkBα	and	IkBα	induced	by	IL-1β	in	the	absence	or	presence	of	EGCG	and/or	catalase.	21	
Western	blot	optical	density	was	evaluated	using	NIH	ImageJ	software	and	data	were	normalized	22	
using	the	optical	density	of	corresponding	β-actin.	23	
*P<0.05	vs	control;	#P<0.05	vs	IL-1β;	**P<0.01	vs	control;	$$P<0.01	vs	IL-1β+EGCG 24	
